XNYSIGC
Market cap18mUSD
Jan 10, Last price
0.35USD
1D
4.12%
1Q
-5.51%
Jan 2017
23.21%
IPO
-99.40%
Name
IGC Pharma Inc
Chart & Performance
Profile
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. It operates through two segments, Infrastructure and Life Sciences. The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand. The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts. It operates in the United States, India, Colombia, and Hong Kong. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 1,345 47.64% | 911 129.47% | 397 -55.79% | |||||||
Cost of revenue | 4,385 | 3,930 | 2,533 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (3,040) | (3,019) | (2,136) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (65) | (412) | ||||||||
Tax Rate | ||||||||||
NOPAT | (3,040) | (2,954) | (1,724) | |||||||
Net income | (13,000) 13.63% | (11,441) -21.66% | (14,604) 62.63% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 3,527 | 103 | 4,145 | |||||||
BB yield | -14.99% | -0.58% | -8.74% | |||||||
Debt | ||||||||||
Debt current | 124 | 133 | 3 | |||||||
Long-term debt | 429 | 688 | 826 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 20 | 21 | 16 | |||||||
Net debt | (645) | (3,480) | (9,999) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (5,199) | (7,047) | (7,462) | |||||||
CAPEX | (138) | (619) | (742) | |||||||
Cash from investing activities | (317) | (235) | (742) | |||||||
Cash from financing activities | 3,524 | 100 | 4,142 | |||||||
FCF | 1,905 | (74) | 3,047 | |||||||
Balance | ||||||||||
Cash | 1,198 | 3,350 | 10,460 | |||||||
Long term investments | 951 | 368 | ||||||||
Excess cash | 1,131 | 4,255 | 10,808 | |||||||
Stockholders' equity | 7,321 | 14,911 | 23,892 | |||||||
Invested Capital | 6,555 | 10,281 | 13,588 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 58,840 | 52,576 | 49,992 | |||||||
Price | 0.40 17.82% | 0.34 -64.22% | 0.95 -46.99% | |||||||
Market cap | 23,536 31.86% | 17,850 -62.37% | 47,437 -36.85% | |||||||
EV | 22,891 | 14,370 | 37,438 | |||||||
EBITDA | (2,403) | (2,362) | (1,485) | |||||||
EV/EBITDA | ||||||||||
Interest | 412 | |||||||||
Interest/NOPBT |